// App-Quantinova.ai

S4484 2015 AHA : Tadalafil Therapy Improves Endothelial Thrombomodulin in Hypoxemic Patients with Pulmonary Arterial Hypertension Associated with the Eisenmenger Syndrome

Researchers

Presenter

  • Nair Y Maeda

Principal Investigators

  • Ana M Thomaz

  • Sonia M.F. Mesquita

  • Sergio P. Bydlowski

  • Antonio A. Lopes

Medical Centers

  • Heart Inst, Univ of Sao paulo, Sao Paulo, Brazil

  • Univ of Sao Paulo Sch of Med, Ribeirao Preto SP, Brazil

  • Pro-Sangue Fndn, Sao Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary arterial hypertension

  • Vasodilation dysfunction

  • Eisenmenger syndrome

  • Hypertension

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

Drug/Treatment

  • Chondroitin sulfate

  • Thrombomodulin alfa

  • Tadalafil

  • Protein C

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved